Evopoint Biosciences
CompanyChina
Evopoint Biosciences develops one asset, in phase 1 (XNW5004 in non-Hodgkin lymphoma). Mostly small molecule; based in China.
- 1
- Asset
- Furthest stage
- Phase 1
- 2
- Trials
- 1
- Signal
Pipeline
1Phase 1, Small molecule, non-Hodgkin lymphoma, peripheral t cell lymphoma
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials2
- Signals1
- Similar companies6